[1] Prevention of recurrent staphylococcal skin infections with low-dose oral clindamycin therapy

[2] Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus

[3] Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient

[4] Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection

[5] Methicillin-resistant S. aureus infections among patients in the emergency department

[6] Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial